Your browser doesn't support javascript.
loading
NCAM1 is the Target of miRNA-572: Validation in the Human Oligodendroglial Cell Line.
Mancuso, Roberta; Agostini, Simone; Marventano, Ivana; Hernis, Ambra; Saresella, Marina; Clerici, Mario.
Affiliation
  • Mancuso R; Don Carlo Gnocchi Foundation IRCCS - ONLUS, Via Capecelatro 66, 20148, Milan, Italy. rmancuso@dongnocchi.it.
  • Agostini S; Don Carlo Gnocchi Foundation IRCCS - ONLUS, Via Capecelatro 66, 20148, Milan, Italy.
  • Marventano I; Don Carlo Gnocchi Foundation IRCCS - ONLUS, Via Capecelatro 66, 20148, Milan, Italy.
  • Hernis A; Don Carlo Gnocchi Foundation IRCCS - ONLUS, Via Capecelatro 66, 20148, Milan, Italy.
  • Saresella M; Don Carlo Gnocchi Foundation IRCCS - ONLUS, Via Capecelatro 66, 20148, Milan, Italy.
  • Clerici M; Don Carlo Gnocchi Foundation IRCCS - ONLUS, Via Capecelatro 66, 20148, Milan, Italy.
Cell Mol Neurobiol ; 38(2): 431-440, 2018 Mar.
Article in En | MEDLINE | ID: mdl-28332001
ABSTRACT
The neural cell adhesion molecule 1 (NCAM1) is a fundamental protein in cell-cell interaction and in cellular developmental processes, and its dysregulation is involved in a number of diseases including multiple sclerosis. Studies in rats suggest that the modulation of NCAM1 expression is regulated by miRNA-572, but no data are available confirming such interaction in the human system. We analyzed whether this is the case using a human oligodendroglial cell line (MO3.13). MO3.13 cells were transfected with miRNA-572 mimic and inhibitor separately; NCAM1 mRNA and protein expression levels were analyzed at different time points after transfection. Results indicated that NCAM1 expression is increased after transfection with miRNA-572 inhibitor, whereas it is decreased after transfection with the mimic (p < 0.005). The interaction between NCAM1 and miRNA-572 was subsequently confirmed in a Vero cell line that does not express NCAM1, by luciferase assay after transfection with NCAM1. These results confirm that miRNA-572 regulates NCAM1 and for the first time demonstrate that this interaction regulates NCAM1 expression in human cells. Data herein also support the hypothesis that miRNA-572 is involved in diseases associated with NCAM1 deregulation, suggesting its possible use as a biomarker in these diseases.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligodendroglia / CD56 Antigen / MicroRNAs Limits: Animals / Humans Language: En Journal: Cell Mol Neurobiol Year: 2018 Document type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligodendroglia / CD56 Antigen / MicroRNAs Limits: Animals / Humans Language: En Journal: Cell Mol Neurobiol Year: 2018 Document type: Article Affiliation country: Italy